Search results
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do...
Simply Wall St. via Yahoo Finance· 5 hours agoProtagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by...
Insider Selling: Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Director Sells 231,548 Shares of Stock
ETF DAILY NEWS· 14 hours agoKaryopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) Director Deepika Pakianathan sold 231,548 shares of the company’s stock in a transaction that ...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 3 days agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
Halozyme Therapeutics (NASDAQ:HALO) Updates FY24 Earnings Guidance
ETF DAILY NEWS· 12 hours agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance ...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 16 hours agoShares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that ...
Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% Higher
ETF DAILY NEWS· 15 hours agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s share price traded up 4.1% during trading on Friday . Several analysts recently weighed in ...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 11 hours agoShares of Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a ...
Akero Therapeutics (NASDAQ:AKRO) Stock Price Up 5.8%
ETF DAILY NEWS· 15 hours agoShares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) shot up 5.8% during mid-day trading on Friday . 196,306 shares were traded during mid-day ...
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Motley Fool via Yahoo Finance· 8 hours agoStructure Therapeutics (NASDAQ: GPCR) might have something cooking that could one day unseat the...
Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 5 hours agoBut while history lauds those rare successes, those that fail are often forgotten; who remembers...